Connection

Don Rockey to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Don Rockey has written about Antibodies, Monoclonal, Humanized.
Don Rockey
Connection Strength
0.144
Antibodies, Monoclonal, Humanized
  1. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology. 2018 10; 155(4):1140-1153.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.